FindTrial
Sign In

recombinant vaccinia-CEA(6D)-TRICOM vaccine

BIOLOGICAL5 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Adult Solid NeoplasmBreast CancerExtensive Stage Small Cell Lung CancerLung CancerRecurrent Colon CancerRecurrent Non-small Cell Lung CancerRecurrent Rectal CancerRecurrent Small Cell Lung Cancer

Phase 1

Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer
TerminatedNCT00009958
National Cancer Institute (NCI)Unspecified Adult Solid Tumor, Protocol Specific
Start: 2000-11-30Updated: 2013-05-16
Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer
TerminatedNCT00088933
National Cancer Institute (NCI)Extensive Stage Small Cell Lung Cancer, Recurrent Colon Cancer, Recurrent Non-small Cell Lung Cancer +5
Start: 2004-06-30Updated: 2014-03-31
Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)
CompletedNCT00217373
National Cancer Institute (NCI)Adult Solid Neoplasm
Start: 2005-06-30End: 2015-03-31Updated: 2015-04-20

Phase 2

Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer
CompletedNCT00052351
National Cancer Institute (NCI)Breast Cancer
Start: 2002-09-30End: 2007-10-31Updated: 2013-06-19

Unknown Phase

Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery
CompletedNCT00091039
National Cancer Institute (NCI)Lung Cancer
Start: 2004-08-31End: 2006-02-28Updated: 2013-06-20